Medical parasitology Books
Springer International Publishing AG Hard Ticks (Acari: Ixodida: Ixodidae)
Book SynopsisTicks of the family Ixodidae, commonly known as hard ticks, occur worldwide and are second only to mosquitoes as vectors of agents pathogenic to humans. Of the 729 currently recognized hard tick species, 283 (39%) have been implicated as human parasites, but the literature on these species is both immense and scattered, with the result that health professionals are often unable to determine whether a particular tick specimen, once identified, represents a species that is an actual or potential threat to its human host. In this book, two leading tick specialists provide a list of the species of Ixodidae that have been reported to feed on humans, with emphasis on their geographical distribution, principal hosts, and the tick life history stages associated with human parasitism. Also included is a discussion of 21 ixodid species that, while having been found on humans, are either not known to have actually fed or may have been misidentified. Additionally, 107 tick names that have appeared in papers on tick parasitism of humans, and that might easily confuse non-taxonomists, are shown to be invalid under the rules of zoological nomenclature. Although the species of ticks that attack humans have long attracted the attention of researchers, few comprehensive studies of these species have been attempted. By gleaning and analyzing the results of over 1,100 scientific papers published worldwide, the authors have provided an invaluable survey of hard tick parasitism that is unprecedented in its scope and detail.Table of ContentsACKNOWLEDGEMENTS INTRODUCTION METHODOLOGY CHAPTER 1 – TICK SPECIES FOUND FEEDING ON HUMANS CHAPTER 2 – TICK SPECIES WRONGLY CONSIDERED PARASITES OF HUMANS CHAPTER 3 – INVALID SPECIES RECORDED FROM HUMANS (synonyms, incertae sedis, nomina dubia, nomina nuda) COMMENTS AND CONCLUSIONS REFERENCES
£139.99
Springer Fachmedien Wiesbaden Malaria: Tödliche Parasiten, spannende Forschung
Book SynopsisFriedrich Frischknecht gibt einen Einblick in die Malaria und die biologische Komplexität der sie auslösenden Parasiten. Der Autor nimmt den Leser mit auf eine Reise von der historischen Entdeckung der Erreger zu den modernen Methoden der Impfstoffentwicklung. Dabei erläutert er, wie genetische Manipulationen helfen, den Parasiten zu verstehen und neuartige Impfansätze zu entwickeln. Er erläutert die Schwierigkeiten, die zur Ausrottung von Malaria zu überwinden sind.Der Autor: Prof. Dr. Friedrich Frischknecht hat nach dem Studium der Biochemie an der Freien Universität Berlin am Europäischen Molekularbiologischen Laboratorium (EMBL) in Heidelberg über Pockenviren promoviert. Nach einem Forschungsaufenthalt am Institut Pasteur in Paris leitet er seit 2005 eine Forschungsgruppe am Universitätsklinikum in Heidelberg und beschäftigt sich mit den molekularen Grundlagen der Bewegung von Malariaparasiten.Table of ContentsHistorisches zur Malaria.- Der komplexe Lebenszyklus der Parasiten.- Sichelzellanämie oder wie Malaria das menschliche Genom beeinflusst.- Von der Grundlagenforschung am Tiermodell zu einem neuen Impfstoff.- Diskussion über die Möglichkeit, Malaria auszurotten.
£9.99
Springer Fachmedien Wiesbaden Malaria: Deadly parasites, exciting research and
Book SynopsisFriedrich Frischknecht gives an insight into malaria and the biological complexity of the parasites that trigger it. The author takes the reader on a journey from the historical discovery of the pathogen to the modern methods of vaccine development. He explains how genetic manipulations help to understand the parasite and to develop novel vaccination approaches. He explains the difficulties that need to be overcome to eradicate malaria.The author: Prof. Dr. Friedrich Frischknecht studied biochemistry at the Freie Universität Berlin and did his PhD on smallpox viruses at the European Molecular Biology Laboratory (EMBL) in Heidelberg. After a research stay at the Institut Pasteur in Paris, he has been head of a research group at the University Hospital in Heidelberg since 2005 and is interested in the molecular basis of the movement of malaria parasites.Table of ContentsMalaria history.- The complex life cycle of parasites.- Sickle cell anemia or how malaria affects the human genome.- From basic animal research to a new vaccine.- Discussion of the possibility of eradicating malaria.
£17.09
Urano Yo Soy Yo Y MIS Parasitos
Book Synopsis
£20.50
Obelisco Candidiasis
Book Synopsis
£9.16
World Health Organization Control and surveillance of human African
Book Synopsis
£32.57
World Health Organization From Malaria control to Malaria elimination
Book Synopsis
£13.34
World Health Organization World Malaria Report 2017
Book Synopsis
£45.60
World Health Organization Trypanosomiase humaine africaine : lutte et
Book Synopsis
£31.35
World Health Organization Strat�gie technique mondiale de lutte contre le
Book Synopsis
£17.10
IARC Schistosomes, liver flukes and Heliobacter pylori
Book Synopsis
£55.61
Jaypee Brothers Medical Publishers Essentials of Medical Parasitology
Book SynopsisThis book is a complete guide to medical parasitology for undergraduate and postgraduate students. The new edition has been fully revised to provide the latest updates and advances in the field, highlighting epidemiology, diagnosis and treatment of numerous parasitic diseases. Presented in bullet format, the text is divided into four main sections, each further sub-divided to cover different parasites. The second edition covers recent advances in laboratory diagnosis, treatment guidelines, vaccine prophylaxis, epidemiology of infectious diseases, and hospital infection control. Each chapter features questions on the topic to assist revision, as well as clinical images, schematic diagrams, tables and flowcharts. Key points Complete guide to medical parasitology for students Fully revised, new edition covering latest advances in the field Includes questions on each topic to assist revision Previous edition (9789351523291) published in 2014 Table of ContentsSection 1 INTRODUCTION General Introduction: Parasitology Section 2 PROTOZOOLOGY Introduction to Protozoa Amoeba Flagellates—I (Intestinal and Genital) Flagellates—II (Hemoflagellates) Apicomplexa—I (Malaria parasite and Babesia) Apicomplexa—II (Opportunistic Coccidian Parasites) Miscellaneous Protozoa Section 3 HELMINTHOLOGY Introduction to Helminths Cestodes Trematodes or Flukes Nematodes—I (Intestinal Nematodes) Nematodes—II (Nematodes of Lower Animals that Rarely Infect Man) Nematodes—III (Somatic Nematodes) Section 4 MISCELLANEOUS Laboratory Diagnosis of Parasitic Diseases Medical Entomology Appendices Appendix I Clinical syndromes in parasitology Appendix II Relative size of morphological forms of parasites Index
£36.10
New India Publishing Agency Parasitology: A Research Guide
Book Synopsis
£141.46
World Scientific Publishing Co Pte Ltd Human Parasites: From Organisms To Molecular
Book SynopsisWhy does the World Health Organization (WHO) put emphasis on neglected tropical diseases (NTDs)? What are the NTDs? Are NTDs found in the United States? Is there any relationship between coronavirus disease 2019 (COVID-19) and NTDs? These are some of the questions being addressed in the book.The aim of this textbook is to introduce a modern synthesis on human parasites of medical importance. Species of parasitic protozoa and helminths are presented in detail, from history and discovery to aspects of genomes and molecular biology, together with life cycle, therapy, drug resistance, and case studies of parasitic diseases useful to the clinicians.
£121.50
Springer Verlag, Singapore Integrated Omics Approaches to Infectious
Book SynopsisThis book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology.Table of ContentsChapter 1_Genomic Classification of Human Pathogens. –Chapter 2_Metagenomics of Human Microbiome. –Chapter 3_Genomic Landscape of Novel Coronavirus (2019-Ncov) Towards Better Diagnosis and Efficient Antiviral Therapies. –Chapter 4_Deciphering the Role of Epigenetic Reprogramming In Host-Pathogen Interactions. –Chapter 5_Applications of Next Generation Sequencing In Infectious Pathogens. –Chapter 6_Bioinformatics Applications in Human Pathogens. –Chapter 7_ Non-Coding RNA Profiling: Potential Application in Infectious Diseases. –Chapter 8_ Microarrays: A Road Map to Uncover Host Pathogen Interactions. –Chapter 9_RNA Sequencing as Strategy to Understand Pathogenesis. –Chapter 10_ Non-Coding RNA as Drug Target against Infectious Diseases. –Chapter 11_ Emerging Transcriptional Approach for Identification of Drug Targets in Human Pathogens. –Chapter 12_ Proteogenomics Applications in Human Pathogens.–Chapter 13_Proteomic Strategies for Understanding Host Pathogen Interactions.–Chapter 14_Antimicrobial and Therapeutic Peptides. –Chapter 15_ Structural Proteomics Guided Design of Antimicrobial Drugs and Vaccines. –Chapter 16_Mechanism of Action of Antimicrobial Agents against Clinically Important Pathogens: A Proteomic Approach. –Chapter 17_Application of Lipidomics in Understanding Host Pathogen Interaction. –Chapter 18_Metabolomics: Advances and Applications In Human Pathogens. –Chapter 19_Host-Pathogen Interactions: Nature Inspired Sialic Acid Based Biointerface Materials. –Chapter 20_Nanoparticles as Therapeutic Nanocargos Affecting Epigenome of Microbial Biofilms. –Chapter 21_Challenges and Prospects in Omics Approach to Pathogens
£161.99
Springer Verlag, Singapore Role of Birds in Transmitting Zoonotic Pathogens
Book SynopsisZoonotic diseases pose a serious threat to global health and economy. Domestic and wild birds play crucial roles in transmission and spread of important zoonotic pathogens, with significant implications on human and avian health. Although zoonotic diseases have been extensively studied, information on various aspects of avian zoonotic pathogens have not been revisited or revised to any great extent. This book is a comprehensive and updated compilation of important zoonotic diseases that are transmitted by domestic and wild birds, and consists of 21 chapters that meticulously describe the (i) etiology and evolution, (ii) complex epidemiology, such as migration pathways in context of disease transmission, (iii) pathogenesis, (iv) clinical signs and necropsy findings, (v) diagnostics including latest molecular assays, and (vi) preventative and control strategies, with an emphasis on therapeutics and prophylaxis, of important zoonotic pathogens (bacterial, fungal, parasitic and viral) of avian origin in humans and birds. Each chapter is aptly supported by interactive tables and figures, and features an updated reference section. This book aims to create awareness and enlighten students of veterinary and human medicine on the role of birds in zoonoses, and would serve as a useful reference for working veterinarians, human doctors, and public health experts.Table of ContentsChapter 1_Introduction and Objectives.- Chapter 2. Presentation of bird migration.- Chapter 2.1.Taxonomic groups involved with migration.- Chapter 2.2. Evolution.- Chapter 2.3. Route of bird migration.- Chapter 2.4. Adaptations and population-level scale.- Chapter 2.5. Flyways and stop-overs.- Chapter 2.6. Significance in disease transmission.- Chapter 3. Bacterial Diseases.- Chapter 3.1. Campylobacter.- Chapter 3.1.1. Introduction.- Chapter 3.1.2. Etiology and classification.- Chapter 3.1.3. Epizootiology.- Chapter 3.1.4. Pathogenesis and mode of transmission.- Chapter 3.1.5. Campylobacteriosis in birds.- Chapter 3.1.6. Public health concerns.- Chapter 3.1.7. Clinical signs and pathological changes.- Chapter 3.1.8. Treatment and control.- Chapter 3.2. Chlamydiosis (Psittacosis, Ornithosis) .- Chapter 3.2.1. Historical background.- Chapter 3.2.2. Etiology and Classification.- Chapter 3.2.3. Epizootiology.- Chapter 3.2.4. Transmission between different birds.- Chapter 3.2.5. Chlamydiosis in Ducks and Geese.- Chapter 3.2.6. Chlamydiosis in human beings.- Chapter 3.2.7. Clinical signs and pathological changes.- Chapter 3.2.8. Treatment and control.- Chapter 3.3. Collibacillosis (E. coli) .- Chapter 3.3.1. Introduction and Historical background.- Chapter 3.3.2. Etiology and classification.- Chapter 3.3.3. Antigenic structure of E. coli.- Chapter 3.3.4. Virulence associated factors.- Chapter 3.3.5. Epizootiology.- Chapter 3.3.6. Escherichia coli ,Wild Birds and the public health concerns.- Chapter 3.3.7. Clinical signs and pathological changes.- Chapter 3.3.8. Treatment and control.- Chapter 3.4. Salmonellosis.- Chapter 3.4.1. Introduction.- Chapter 3.4.2. Etiology.- Chapter 3.4.3. Epizootiology.- Chapter 3.4.4. Wild birds as a carrier for Salmonellosis.- Chapter 3.4.5. Modes of transmission and Pathogenesis.- Chapter 3.4.6. Salmonellosis and public health concerns.- Chapter 3.4.7. Clinical signs and pathological changes.- Chapter 3.4.8. Treatment and control.- Chapter 3.5. Avian Tuberculosis.- Chapter 3.5.1. Introduction and Historical background.- Chapter 3.5.2. Etiology.- Chapter 3.5.2. Epizootiology.- Chapter 3.5.3. Pathogenesis.- Chapter 3.5.4. Mycobacterium in wild birds.- Chapter 3.5.5. Public health concerns to Mycobacteriosis.- Chapter 3.5.6. Clinical signs and pathological changes.- Chapter 3.5.7. Treatment and control. .- Chapter 3.6. Lyme Disease (Borrelia spp) .- Chapter 3.6.1. Introduction and Historical background.- Chapter 3.6.2. Etiology.- Chapter 3.6.3. Epizootiology.- Chapter 3.6.4. Avian Spirochetosis.- Chapter 3.6.5. Lyme Borreliosis in North America.- Chapter 3.6.6. Lyme Borreliosis in Europe.- Chapter 3.6.7. Pathogenesis.- Chapter 3.6.8. Clinical signs and pathological changes.- Chapter 3.6.9. Treatment and control.- Chapter 3.7. Avian Erysipeplas.- Chapter 3.7.1. Introduction and Historical background.- Chapter 3.7.2. Etiology.- Chapter 3.7.3. Epizootiology.- Chapter 3.7.4. Public health and animal health concerns.- Chapter 3.7.5. Erysiplothrix impact on the wild birds.- Chapter 3.7.6. Pathogenesis.- Chapter 3.7.7. Clinical signs and pathological changes.- Chapter 3.7.8. Treatment and control.- Chapter 3.8. Clostridia disease (Avian Botulism) .- Chapter 3.8.1. Introduction and Historical background.- Chapter 3.8.2. Etiology.- Chapter 3.8.3. Epizootiology.- Chapter 3.8.4. Public health concerns.- Chapter 3.8.5. Pathogenesis.- Chapter 3.8.6. Clinical signs and pathology.- Chapter 3.8.7. Treatment and control.- Chapter 3.9. Avian Cholera.- Chapter 3.9.1. Introduction and Historical background.- Chapter 3.9.2. Epizootiology.- Chapter 3.9.3. Pathogenesis.- Chapter 3.9.4. Public health and animal health concerns.- Chapter 3.9.5. Clinical signs and pathological changes.- Chapter 3.9.6. Impact of P. multocida on the wildlife populations.- Chapter 3.9.7. Treatment and control.- Chapter 3.10. Spotted Fever Group of Rickettsiales.- Chapter 3.10.1. Introduction and Historical background.- Chapter 3.10.2. Epizootiology and Pathogenesis.- Chapter 3.10.3. Clinical signs and pathology.- Chapter 3.10.4. Public health and animal health concerns.- Chapter 3.10.5. Treatment and control.- Chapter 4. Viral Diseases.- Chapter 4.1. Flaviviruses (West Nile Virus and Japanese encephalitis virus).- Chapter 4.1.1. Introduction and Historical background.- Chapter 4.1.2. Etiology.- Chapter 4.1.3. Epizootiology and pathogenesis.- Chapter 4.1.4. Natural Host and Age susceptibility.- Chapter 4.1.5. Mode of transmission and Incubation period.- Chapter 4.1.6. Clinical signs, Necropsy finding and Pathological changes.- Chapter 4.1.7. Disease in human.- Chapter 4.1.8. Prevention and control measures and vaccination protocols.- Chapter 4.2. Togavirus (Western Equine encephalitis virus).- Chapter 4.2.1. Introduction and Historical background.- Chapter 4.2.2. Etiology.- Chapter 4.2.3. Epizootiology and pathogenesis.- Chapter 4.2.4. Natural Host and Age susceptibility.- Chapter 4.2.5. Mode of transmission and Incubation period.- Chapter 4.2.6. Clinical signs, Necropsy finding and Pathological changes.- Chapter 4.2.7. Immune response and Diagnosis.- Chapter 4.2.8. Control measures and vaccination protocols.- Chapter 4.3. Avian Influenza.- Chapter 4.3.1. Introduction.- Chapter 4.3.2. Etiology and classification.- Chapter 4.3.3. Epizootiology.- Chapter 4.3.4. Incidence and distribution of AI.- Chapter 4.3.5. Hosts and Host restrictions.- Chapter 4.3.6. Methods of transmission.- Chapter 4.3.7. Public Health Concerns.- Chapter 4.3.8. AI impact on the wild life population.- Chapter 4.3.9. Domestic animal concerns regarding AI.- Chapter 4.3.10. Clinical signs.- Chapter 4.3.11. Treatment and control.- Chapter 4.4. Newcastle disease virus (NDV) and other avian paramyxoviruses.- Chapter 4.4.1. Introduction, Synonyms, and Historical background.- Chapter 4.4.2. Etiology and strain classification.- Chapter 4.4.3. Epizootiology.- Chapter 4.4.4. Geographical distribution and incidence of the NDV.- Chapter 4.4.5. NDV modes of spread.- Chapter 4.4.6.NDV Public Health Concerns.- Chapter 4.4.7. Clinical signs.- Chapter 4.4.8. Necropsy findings.- Chapter 4.4.9. Pathogenesis.- Chapter 4.4.10. Diagnosis and Control measures.- Chapter 4.4.11. Treatment and control.- Chapter 4.5. Circovirus.- Chapter 4.5.1. Introduction.- Chapter 4.5.2. Etiology and classification.- Chapter 4.5.3. Psittacine Beak and Feather Disease.- Chapter 4.5.4. Historical background and introduction.- Chapter 4.5.5. Epizootiology and modes of transmission.- Chapter 4.5.6. Pathogenesis.- Chapter 4.5.7. Public health and animal health concerns.- Chapter 4.5.8. Goose and Duck Circoviruses.- Chapter 4.5.9. Diagnosis and Control measures.- Chapter 4.6. Rotavirus.- Chapter 4.6.1. Introduction and Historical background.- Chapter 4.6.2. Etiology and classification.- Chapter 4.6.3. Epizootiology.- Chapter 4.6.4. Pathogenesis.- Chapter 4.6.5. Clinical signs and pathology.- Chapter 4.6.6. Control measures.- Chapter 4.7. Usutu virus.- Chapter 4.7.1 Introduction and Historical background.- Chapter 4.7.2. Etiology and classification.- Chapter 4.7.3. Epizootiology.- Chapter 4.7.4. Pathogenesis.- Chapter 4.7.5. Clinical signs and pathology.- Chapter 4.7.6. Diagnosis.- Chapter 4.7.7. Control measures.- Chapter 5. Parasitic diseases.- Chapter 5. Cryptosporidiosis.- Chapter 5.1. Introduction.- Chapter 5.1.1. Epizootiology.- Chapter 5.1.2. Modes of transmission.- Chapter 5.1.3. Prevalence of the cryptosporidiosis.- Chapter 5.1.4. Cryptosporidiosis in Canada Geese.- Chapter 5.1.5. Pathogenesis and Cryptosporidiosis in human beings.- Chapter 5.1.6. Diagnosis and Control measures.- Chapter 5.1.7. Treatment and control.- Chapter 5.2. Giardiasis.- Chapter 5.2.1. Introduction.- Chapter 5.2.2. Epizootiology.- Chapter 5.2.3. Mode of transmission.- Chapter 5.2.4. Pathogenesis.- Chapter 5.2.5. Giardiasis and Canada Goose.- Chapter 5.2.6 Giardiasis in human beings.- Chapter 5.2.7. Diagnosis and Control measures.- Chapter 5.2.8. Treatment and control.- Chapter 5.3. Role of birds in tick-borne diseases .- Chapter 5.3.1. Introduction.- Chapter 5.3.2. Epizootiology and Mode of transmission.- Chapter 5.3.3. Tick-borne diseases.- Chapter 5.3.4. CCHF and Dermanyssus gallinae.- Chapter 5.3.5. Diagnosis and Control measures.- Chapter 5.3.6. Treatment and control.- Chapter 6. Mycotic Diseases.- Chapter 6.1. Aspergillosis- Chapter 6.1.1. Introduction and Historical background- Chapter 6.1.2. Epizootiology- Chapter 6.1.3. Mode of transmission- Chapter 6.1.4. Pathogenesis- Chapter 6.1.5. Public health and animal health concerns- Chapter 6.1.6. Clinical signs and necropsy findings- Chapter 6.1.7. Diagnosis and Control measures- Chapter 6.1.8. Treatment and control- Chapter 6.2. Dermatophytosis (Favus) - Chapter 6.3. Dactylariosis- Chapter 6.4. Histoplasmosis- Chapter 6.5. Cryptococcosis. - Chapter 6.6. Role of birds as vectors of fluke worms (Trichobilharzia szidati) - Chapter 7. Sporadic diseases affecting wild birds and of non-zoonotic importance- Chapter 7.1. Mycoplsmosis- Chapter 7.2. Ornithobacterium rhinotraheale- Chapter 7.3. Avian Herpesvirus- Chapter 7.4. Avian Pox- Chapter 7.5 Avian adenoviruses- Chapter 7.6. Retrovirus infections- Chapter 7.7. Paplomaviruses and Polyomaviruses.- Chapter 8. Conclusions.- Chapter 9. Glossary- Chapter 10. List of abbreviations- Chapter 11. References.
£116.99
Springer Verlag, Singapore Pathobiology of Parasitic Protozoa: Dynamics and
Book SynopsisThis book illustrates the importance and significance of the systems approach in deciphering diverse aspects of host-parasite interactions in infection dynamics. It describes the complex issues and state-of-the-art progress in the infection biology of parasitic protozoa. The book explores the current concepts and paradigms of gene expression, metabolome, and immune remodeling in these diseases. The chapters encompass updates on the parasitic tropism, co-evolution, systemic responses in hosts, and translational approaches. It provides an overview of the parasite's efficient ways of exploiting host molecules and describes pathways for their survival, differentiation, and replication within the host cells. The book also delineates the role of inflammasomes and their activation in response to the protozoan parasite. The book discusses technological progress and machine learning-based modeling approaches to revisit parasitic infection from a non-conventional perspective. Collectively this book offers a comprehensive purview of concepts and paradigms in parasitic infection in the form of an updated yet discernible elucidation. Table of Contents1.Nanotechnology-based promising therapeutic approaches against protozoan.- 2. Intertwining of retinoic acid and cholesterol pathway and its consequences in Leishmania donovani infected macrophages.- 3. Role and pathophysiology of protozoan parasites causing liver diseases.- 4. Cognitive Impairment in Parasitic Protozoan Infection.- 5. Cycling Within a Cell: Cell Cycle of Intracellular Kinetoplastid Parasites.- 6. Elaborating role of aspartyl protease in host modulation and invasion in Apicomplexan parasites Plasmodium and Toxoplasma.- 7. Leishmaniasis: Tissue tropism in relation to the species diversity.- 8. Transcriptional control in Entamoeba: Something old, Something new.- 9. A perspective on mathematical modeling and machine learning models to predict Visceral Leishmaniasis.- 10. Elucidating the Role of miRNA in Inflammasome Mediated Immune Response in Leishmaniasis.- 11. An Insight into Immunopathology of Leishmaniasis.
£125.99
Springer Verlag, Singapore Natural Product Based Drug Discovery Against
Book SynopsisThis book comprehensively reviews current and novel treatment strategies against human parasites, including protozoans and helminths, using natural products. The initial chapters summarize the conventional treatment strategies and natural-product based therapeutics against these parasites. It discusses biochemical tools and techniques for the discovery of natural product based drugs against human parasites. The book also covers the ingenious and innovative mechanisms to achieve drug resistance by the protozoan parasites and strategies to overcome the resistance. It entails mechanistic insight into the modulation of host immune responses to delay or inhibit parasite clearance and explores host-pathogen interactions that mediate immunity against subsequent parasite challenge. In turn, the volume helps in understanding the immunobiology of the parasites and tools to identify candidate vaccine antigens and novel delivery systems against the protozoan parasites. Lastly, it explores the role of advanced methods, including nanotechnology, marine bioprospecting, and microorganisms-derived biochemicals against the protozoan parasites.This book is useful for students and researchers of pharmacology, parasitology, zoology and other allied fields.Table of Contents
£197.99
Nova Science Publishers Inc Parasitology: Risks and Challenges for Health and
Book Synopsis
£138.39
